Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
.jpg)
January 04, 2021
Early registration rates for ENDO 2021 expire on Thursday, January 21! Register today at our best rates and join us virtually March 20-23 as prominent members of endocrinology community come together to share new innovations and developments in hormone health and science.
January 04, 2021
This is the final opportunity to submit an abstract to ENDO 2021! ENDO represents the best opportunity to share your research with your colleagues in endocrinology and contribute to the advancement of our field. Submit your abstract by January 28, 2021 at 1:00 PM EST to ensure you are considered.
January 15, 2021
The discovery of insulin in 1921 transformed diabetes from a death sentence to a chronic condition. We’re celebrating the 100th anniversary of insulin with this collection of resources and member stories. Check back regularly for updates and events, including webinars and podcasts, throughout the year.
January 05, 2021
Submit by Tuesday, January 19. The Research Experiences for Graduate and Medical Students (REGMS) program, formerly the Summer Research Fellowship program, includes involvement in a variety of engaging programs for early career scientists and a $2,500 honorarium.
January 14, 2021
We share the latest about insulin pricing, the Medicare Physician Fee Schedule, and the extension of the COVID-19 Public Health Emergency.
Need more info?
Learn more about the advantages of membership
January 12, 2021
The Endocrine Society is calling on policymakers to include government negotiation as part of an overall strategy to reduce insulin prices in its updated position statement published today in The Journal of Clinical Endocrinology & Metabolism.
January 08, 2021
Black and Hispanic people with COVID-19 and diabetes are more likely than Caucasians to die or have serious complications, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
December 22, 2020
Machine learning, a form of artificial intelligence, can predict which women are at high risk of developing gestational diabetes and lead to earlier intervention, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.